| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/25/2004 | WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004024673A1 Amino-propanol derivatives |
| 03/25/2004 | WO2004024186A2 Treatment of cyclooxygenase-3 mediated diseases and disorders |
| 03/25/2004 | WO2004024174A1 Method and composition for regulating the activity of regulatory t cells |
| 03/25/2004 | WO2004024142A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 03/25/2004 | WO2004024141A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 03/25/2004 | WO2004024132A2 Use of no-signal cascade modulators and pharmaceutical composition |
| 03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | WO2004024086A2 Compounds, compositions and methods |
| 03/25/2004 | WO2004023870A1 Human slt transgenic animal |
| 03/25/2004 | WO2004014367A3 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004013138A3 Imidazo`1,2-a!pyridines |
| 03/25/2004 | WO2004005547A3 Method for identifying hypersensitive site consensus sequences |
| 03/25/2004 | WO2004004665A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 03/25/2004 | WO2004000849A3 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 03/25/2004 | WO2004000808A3 N-substituted piperidine derivatives as serotonin receptor agents |
| 03/25/2004 | WO2004000801A3 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/25/2004 | WO2003103676A3 Method of treating cancer using kinase inhibitors |
| 03/25/2004 | WO2003098992A3 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 03/25/2004 | WO2003092624A3 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 03/25/2004 | WO2003090726A3 Chewable soft capsule |
| 03/25/2004 | WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same |
| 03/25/2004 | WO2003086318A3 Improved prodrugs of cc-1065 analogs |
| 03/25/2004 | WO2003086306B1 5ht2c receptor modulators |
| 03/25/2004 | WO2003086287A3 Compounds and methods for inducing apoptosis in proliferating cells |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003084926A3 Polymeric acyl derivatives of indoles |
| 03/25/2004 | WO2003080070A3 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
| 03/25/2004 | WO2003077949A3 Methods of treating diabetes using pde 11a inhibitors |
| 03/25/2004 | WO2003077862A3 Potent, simplified derivatives of immunosuppressive agents |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003072195A3 Method for administering glp-1 molecules |
| 03/25/2004 | WO2003066104A3 Pharmaceutical composition which improves in vivo gene transfer |
| 03/25/2004 | WO2003059372A3 Combined use of a glp-1 compound and a modulator of diabetic late complications |
| 03/25/2004 | WO2003059266A3 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs |
| 03/25/2004 | WO2003055443A3 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003048106A3 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 03/25/2004 | WO2003046578A3 Method for the assessment and prognosis of sarcoidosis |
| 03/25/2004 | WO2003037860A3 Purine analogs having hsp90-inhibiting activity |
| 03/25/2004 | WO2003037361A3 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | WO2003015612A3 Materials and methods to promote repair of nerve tissue |
| 03/25/2004 | WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | WO2003000343A3 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 03/25/2004 | WO2002102399A3 Mucosal repair by tff2 peptides |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002066044A3 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002017899A3 Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| 03/25/2004 | US20040059383 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 03/25/2004 | US20040059140 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile |
| 03/25/2004 | US20040059136 7-carboxy-flavone derivatives preparation method and therapeutic use |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059118 Which inhibit thrombin |
| 03/25/2004 | US20040059116 Aryl aniline beta2 adrenergic receptor agonists |
| 03/25/2004 | US20040059115 Such as ((benzylsulfonylamino)methyl)-phosphonic acid mono-(4-nitrophenyl)ester sodium salt; for treating bacterial antibiotic resistance |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040059110 Such as N,N'-bis(2-hydroxybenzyl)-L-cystine |
| 03/25/2004 | US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics |
| 03/25/2004 | US20040059107 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; pharmaceutical formulations, improved cell and organ culture media, cryopreservation media, antiaging, chemoprotective and radioprotective uses |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040059017 Method for producing a partial or complete active ingredient coating on and in implants and onplants |
| 03/25/2004 | US20040058993 Prevention, therapy of liver disorders; using aminomethanesulfonic acid |
| 03/25/2004 | US20040058990 Thrombopoietin mimetics |
| 03/25/2004 | US20040058988 Fatty acid synthase inhibitors |
| 03/25/2004 | US20040058987 Hypotensive agents; oxidation resistance, nitrogen scavenger; anticancer agents; antiischemic agents |
| 03/25/2004 | US20040058986 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 03/25/2004 | US20040058984 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058978 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs |
| 03/25/2004 | US20040058972 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 03/25/2004 | US20040058969 React with tubulin; forming microtubes; stabilization; antitumor, anticancer agents; antiinflammatory agnets; psoriasis; antiarthritic agents |
| 03/25/2004 | US20040058965 Alkanoic acid derivatives process for their production and use thereof |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058963 Cardiovascular disorders; hypotensive agents; antiallergens; antihistamines; antiarthritic agents; skin disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058958 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 03/25/2004 | US20040058952 Urease inhibitors |
| 03/25/2004 | US20040058949 Novel salt and polymorphs of desloratadine hemifumarate |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058940 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058925 Method of treating fibromyalgia and other somatoform disorders |
| 03/25/2004 | US20040058921 Psychological disorders; antidepressants; sexual disorders ; eating disorders |
| 03/25/2004 | US20040058920 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 03/25/2004 | US20040058915 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/25/2004 | US20040058914 Combination drugs |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058909 Method of treatment |
| 03/25/2004 | US20040058907 Compounds useful in the treatment of inflammatory diseases |
| 03/25/2004 | US20040058905 FKBP inhibitors |